KIR3DL1 and neoplasm: By the same way it is plausible that some peptides (new or only more abundant) may be presented by HLA to KIR in the course of cancer growth, or even edited due to mCRC treatment, and thus that peptides/HLA complexes may influence the NK cell function at site of the tumor [58]; [59]–[64].